Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Camp4 Therapeutics Corporation (NASDAQ: CAMP)
CAMP Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-17.60%
Analyst Rating:
BUY
Analyst Forecast (1yr):
5.20%
CAMP Stock Analysis
CAMP
PE Ratio:
CAMP
PEG Ratio:
Not Available
CAMP
Forward EPS Growth (12 month):
0.00%
CAMP
PS Ratio:
22.5
CAMP
PSG Ratio:
-2.9
CAMP
Forward Revenue Growth (12 month):
-7.60%
CAMP Articles
No data was found